Brett Sandercock insider trades

Open-market stock purchases and sales by Brett Sandercock, Chief Financial Officer at Resmed Inc, from SEC Form 4 filings since Feb 17, 2010.

Recent trades

DateStockTradeValue
Apr 1, 2026RMD Resmed IncSold$224K
Mar 2, 2026RMD Resmed IncSold$254K
Feb 2, 2026RMD Resmed IncSold$257K
Jan 2, 2026RMD Resmed IncSold$242K
Dec 1, 2025RMD Resmed IncSold$244K
Nov 20, 2025RMD Resmed IncBought (not open market)—
Nov 3, 2025RMD Resmed IncBought (not open market)—
Nov 3, 2025RMD Resmed IncSold$743K

Companies traded

  • RMD Resmed Inc: 129 sales, last Apr 1, 2026

Get free alerts when Brett Sandercock files a new trade →